For research use only. Not for therapeutic Use.
MAO-B-IN-17（Cat No.:I042831）is a selective inhibitor of the Monoamine Oxidase B (MAO-B) enzyme, which plays a critical role in the breakdown of neurotransmitters like dopamine and phenylethylamine in the brain. By inhibiting MAO-B, this compound helps to increase the levels of these neurotransmitters, which can be beneficial in treating neurological disorders such as Parkinson’s disease and Alzheimer’s disease. MAO-B-IN-17 is used in preclinical research to study the effects of MAO-B inhibition on neurodegenerative diseases and to evaluate its potential for improving cognitive function and motor symptoms in patients with dopamine-related disorders.
| CAS Number | 2890188-81-3 |
| Synonyms | 2-(3,5-difluorophenyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline |
| Molecular Formula | C17H17F2NO2 |
| Purity | ≥95% |
| IUPAC Name | 2-(3,5-difluorophenyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline |
| InChI | InChI=1S/C17H17F2NO2/c1-21-16-5-11-3-4-20(10-12(11)6-17(16)22-2)15-8-13(18)7-14(19)9-15/h5-9H,3-4,10H2,1-2H3 |
| InChIKey | XZTKRGSHRFWZIG-UHFFFAOYSA-N |
| SMILES | COC1=C(C=C2CN(CCC2=C1)C3=CC(=CC(=C3)F)F)OC |
